IDX Shares Integral Diagnostics Limited
ASX · ASXLast in our picks 2026-10-23 — not in the current list; analysis below is from that screen
Imaging demand and consolidation potential offer recovery upside following recent sector underperformance.
Future value: $2.99 (+43.03%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Healthcare rebound but negative twelve-month performance
- ▾Below 50-day MA (-6.09%)
- ▸~43% upside to price target
Is IDX a buy right now?
Trend: IDX is trading below the 50-day average (-4.05%), RSI 46 — neutral momentum, with a 3-month return of +1.43%.
Valuation & quality: Integral Diagnostics Limited trades on a trailing P/E of 35.5, forward P/E 13.7, price-to-book 1.17; fundamentals show net margin 2.8%, return on equity 3.2%, revenue growth 5.6% year on year.
Analyst consensus: 13 analysts have a mean 12-month price target of A$2.99 (+40.3% vs the last close; range A$2.24 – A$3.70), consensus rating “none”.
Income: trailing dividend yield 4.45%.
Our screen: ACCUMULATE (score 1) — Imaging demand and consolidation potential offer recovery upside following recent sector underperformance.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -4.90% | -3.90% | -2.70% | -7.80% | +5.00% | +9.00% | -5.20% | -1.80% |
Fundamentals
Analyst price target
Technical signals
About Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand.
Sector: Healthcare · Industry: Diagnostics & Research · Australia · 3,049 employees · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.